Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics (NASDAQ:AVTX – Get Free Report) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.98) earnings per share for the quarter, beating the consensus estimate of ($1.00) by $0.02. On average, research analysts forecast that Avalo Therapeutics …

Avalo Therapeutics was recently added to a broad range of Russell indices, including the Russell 2000, 2500, 3000 and related growth, value and small-cap benchmarks, following index reconstitutions completed in June 2026. This unusually wide index inclusion amplifies Avalo’s visibility across ...

See the latest Avalo Therapeutics Inc stock price (AVTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

Avalo Therapeutics, Inc. (NASDAQ:AVTX) is among the best low priced stocks to get rich in 2026. On June 12, BofA started coverage on Avalo Therapeutics, Inc. (NASDAQ:AVTX) with a Buy rating and a price target of $35. According to the firm, the company is a “cleaner, single-asset immunology ...

Aevex just secured a major $50 million U.S. Air Force contract, putting the newly public defense company firmly on investors’ radar.